| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-13 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |